LOGC
$8.48
Logicbio Therapeutics
($.27)
(3.09%)
LOGC
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.43)
Revenue:  N/A
Monday
Nov 9
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LOGC reports earnings?
Beat
Meet
Miss

Where is LOGC's stock price going from here?
Up
Flat
Down
Stock chart of LOGC
Analysts
Summary of analysts' recommendations for LOGC
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
LOGIC DEVICES develops and markets high-performance digital integrated circuits that address the requirements of original equipment manufacturers (OEMs) to provide high-speed electronic computation in digital signal processing (DSP), video image processing, and telecommunications applications. The Company's product strategy is to develop and market proprietary circuits that offer superior performance to meet specific application requirements.